JQLCX
Price
$12.08
Change
+$0.03 (+0.25%)
Updated
Jul 9 closing price
Net Assets
1.59B
VASIX
Price
$15.52
Change
+$0.06 (+0.39%)
Updated
Jul 9 closing price
Net Assets
3.94B
Interact to see
Advertisement

JQLCX vs VASIX

Header iconJQLCX vs VASIX Comparison
Open Charts JQLCX vs VASIXBanner chart's image
JHancock Multimanager Lifestyle Cnsrv R2
Price$12.08
Change+$0.03 (+0.25%)
VolumeN/A
Net Assets1.59B
Vanguard LifeStrategy Income I
Price$15.52
Change+$0.06 (+0.39%)
VolumeN/A
Net Assets3.94B
JQLCX vs VASIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JQLCX vs. VASIX commentary
Jul 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JQLCX is a Hold and VASIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VASIX has more cash in the bank: 3.94B vs. JQLCX (1.59B). JQLCX (3.63) and VASIX (3.53) have matching dividends . JQLCX was incepted earlier than VASIX: JQLCX (13 years) vs VASIX (31 years). JQLCX (1.32) is less costly to investors than VASIX (0.11). JQLCX is a more actively managed with annual turnover of: 16.00 vs. VASIX (5.00). JQLCX has a lower initial minimum investment than VASIX: JQLCX (0) vs VASIX (3000). JQLCX annual gain was more profitable for investors over the last year : 7.20 vs. VASIX (4.59). JQLCX return over 5 years is better than : 9.31 vs. VASIX (3.64).
JQLCXVASIXJQLCX / VASIX
Total Expense Ratio1.320.111,200%
Annual Report Gross Expense Ratio1.320.111,200%
Fund Existence13 years31 years-
Gain YTD4.5964.73597%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.59B3.94B40%
Annual Yield % from dividends3.633.53103%
Returns for 1 year7.204.59157%
Returns for 3 years16.4213.31123%
Returns for 5 years9.313.64256%
Returns for 10 years21.0129.3772%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NRDY1.660.02
+1.22%
Nerdy
AVPT18.830.20
+1.07%
AvePoint
HOWL1.070.01
+0.94%
Werewolf Therapeutics
HRB55.610.33
+0.60%
H&R Block
NVO69.690.05
+0.07%
Novo-Nordisk A/S